Clinical trial
Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
NCT00204620 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204620 |
|---|---|
| Title | Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS) |
| Official title | Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma |
| Lead sponsor | University Hospital Tuebingen, Other |
| Collaborators | Arbeitsgemeinschaft fur Internistische Onkologie German Sarcoma Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Soft Tissue |
| Intervention type | Drug |
| Interventions | Bendamustin |
| Enrollment | 28 |
| Start date | Mar 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 20, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: